Verrica Pharmaceuticals Inc.
- Last sale
- Nov 5, 2026 · -9.14%
- Market cap
- $52.91M
- 17.18M shares
- Filings
- 538
Q3 2026+370.2% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−34.9% FY25 yoy
- $52.91M
- —
- 2.3×
- —
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 5, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $35,577,000 | reported | |
| FY 2024 | 2024-12-31 | $7,566,000 | reported | |
| FY 2023 | 2023-12-31 | $5,124,000 | reported | |
| FY 2022 | 2022-12-31 | $9,032,000 | reported | |
| FY 2021 | 2021-12-31 | $12,000,000 | reported |
Segments
Products
LineFY2025ShareChange
License and Collaboration Revenue, Commercial Supply and Development$2.30M6.5%+130.0%
Collaboration———
Product———
Total$35.58M
Pharmaceutical preparations
Verrica Pharmaceuticals Inc. is the 142nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
BGMBGM Group Ltd.$37.9M51.1%52.6%—LIFDLFTD Partners Inc.$36.9M1.1%67.3%$3.7MSBFMSunshine Biopharma Inc.$36.3M4.1%16.5%$2.4METSTEarth Science Tech, Inc.$35.7M7.8%10.2%$25.9M
VRCAVerrica Pharmaceuticals Inc. (this company)$35.6M370.2%50.3%$52.9M
BHSTBioharvest Sciences Inc.$34.5M37.0%32.3%$39.7MZOMDFZomedica Corp.$32.0M17.4%255.6%$78.4MVSTMVerastem, Inc.$30.9M209.1%677.6%$1.1BFHTXFoghorn Therapeutics Inc.$30.9M36.8%240.3%$123.5MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Verrica Pharmaceuticals Inc. · CIK 1660334 · Engraved from SEC EDGAR